References

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2021 · External reference

Precision treatment in advanced hepatocellular carcinoma

10.1016/j.ccell.2024.01.007 · 2024 · External reference

Liver transplantation as therapy for hepatocellular carcinoma

10.1111/liv.14346 · 2020 · External reference

Liver transplantation for pediatric liver malignancies

10.1097/lvt.0000000000000470 · 2025 · External reference

Management of hepatocellular carcinoma recurrence after liver transplantation

10.1016/j.aohep.2021.100654 · 2022 · External reference

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

10.1056/nejm199603143341104 · 1996 · External reference

Beyond the milan criteria for liver transplantation in children with hepatic tumours

10.1016/s2468-1253(17)30084-5 · 2017 · External reference

Prediction models of hepatocellular carcinoma recurrence after liver transplantation: a comprehensive review

10.3350/cmh.2022.0060 · 2022 · External reference

Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation

10.1111/jgh.16693 · 2024 · External reference

Serial circulating tumor DNA profiling predicts tumor recurrence after liver transplantation for liver cancer

10.1007/s12072-023-10594-x · 2024 · External reference

Gadoxetic acid–enhanced MRI as a predictor of recurrence of HCC after liver transplantation

10.1007/s00330-019-06424-0 · 2020 · External reference

Serum biomarkers and risk of hepatocellular carcinoma recurrence after liver transplantation

10.4254/wjh.v11.i1.50 · 2019 · External reference

Magnetic resonance imaging in diagnosis and monitoring of hepatocellular carcinoma in liver transplantation: a comprehensive review

10.12659/aot.895595 · 2016 · External reference

Fat fraction quantification by MRI predicts diagnosis and prognosis of HBV-Related steatohepatitic hepatocellular carcinoma

10.1007/s00330-024-11151-2 · 2025 · External reference

MRI proton density fat fraction for estimation of tumor grade in steatotic hepatocellular carcinoma

10.1007/s00330-023-09864-x · 2023 · External reference

Fat fraction quantification with MRI estimates tumor proliferation of hepatocellular carcinoma

2024 · External reference

MRI proton density fat fraction for estimation of biological characteristics in hepatocellular carcinoma

10.1186/s12880-025-01789-9 · 2025 · External reference

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC

10.1016/j.jhep.2016.10.038 · 2017 · External reference

The growing impact of alpha-fetoprotein in the field of liver transplantation for hepatocellular cancer: time for a revolution

10.21037/tgh.2017.09.05 · 2017 · External reference

AFP ratio predicts HCC recurrence after liver transplantation

10.1371/journal.pone.0235576 · 2020 · External reference

Related factors of hepatocellular carcinoma recurrence associated with hyperglycemia after liver transplantation

10.1016/j.transproceed.2020.10.027 · 2021 · External reference

Elevated preoperative serum gamma-glutamyltranspeptidase predicts poor prognosis for hepatocellular carcinoma after liver transplantation

2016 · External reference

Noninvasive urinary protein signatures combined clinical information associated with microvascular invasion risk in HCC patients

10.1186/s12916-023-03137-6 · 2023 · External reference